SLP (Simulations Plus) 1-Year Sharpe Ratio: 0.28 (As of Jul. 13, 2026)


SLP Simulations Plus Inc SLP
85 GF Score
Price $18.27
GF Value $35.40
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Simulations Plus 1-Year Sharpe Ratio?

Simulations Plus SLP +0.08% 85 1-Year Sharpe Ratio is 0.28 as of Jul. 13, 2026. GuruFocus rates SLP with a GF Score™ of 85/100 and a GF Value™ of $35.40 (Significantly Undervalued). The stock has 7 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-13), Simulations Plus's 1-Year Sharpe Ratio is 0.28.

Simulations Plus  (NAS:SLP) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Simulations Plus 1-Year Sharpe Ratio Related Terms

SLP vs TBRG, CARL, NRC: 1-Year Sharpe Ratio Comparison

For the Health Information Services subindustry, Simulations Plus's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Simulations Plus 1-Year Sharpe Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Simulations Plus's 1-Year Sharpe Ratio falls into.


SLP
85GF Score
Simulations Plus Inc SLP
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Simulations Plus 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 0.28 mean?
Simulations Plus (SLP) has a 1-Year Sharpe Ratio of 0.28 as of Jul. 13, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Simulations Plus and its competitors.
Is Simulations Plus' 1-Year Sharpe Ratio too high?
Simulations Plus' current 1-Year Sharpe Ratio is 0.28. Overall, Simulations Plus has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Simulations Plus' 1-Year Sharpe Ratio compare to TBRG and CARL?
Simulations Plus' 1-Year Sharpe Ratio of 0.28 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Healthcare Providers & Services company?
A good 1-Year Sharpe Ratio depends on the Healthcare Providers & Services industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Simulations Plus and its competitors. Simulations Plus's current 1-Year Sharpe Ratio is 0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simulations Plus stock overvalued right now?
Based on GuruFocus' analysis, Simulations Plus (SLP) is currently considered Significantly Undervalued. The stock's GF Value™ is $35.40, compared to a current price of $18.27 — trading 48.4% below its estimated fair value. The current 1-Year Sharpe Ratio is 0.28. Simulations Plus' overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Simulations Plus (SLP), the current 1-Year Sharpe Ratio is 0.28 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Simulations Plus (SLP) Overvalued in 2026?

Based on GuruFocus' analysis, Simulations Plus stock appears to be undervalued. The current stock price of $18.27 is trading 48.4% below its estimated GF Value™ of $35.40. GuruFocus considers Simulations Plus to be Significantly Undervalued.

Key valuation signals for SLP:

  • 1-Year Sharpe Ratio: 0.28
  • GF Value™: $35.40 vs. price of $18.27 (48.4% below fair value)
  • GF Score™: 85/100 with 7 warning signs

No single metric tells the full story. See the SLP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Simulations Plus Business Description

Other Exchanges SD3:Germany
Address 800 Park Offices Drive, Suite 401, Research Triangle Park, Lancaster, NC, USA, 27709
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
85GF Score

Get the complete analysis for SLP

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.27
Price
$35.40
GF Value